Key Advantages

The Algernon Value Proposition

  • Advancing new drug treatments for billion dollar global disease markets.


  • Advancing 4 lead compounds that either out performed or matched the gold standard of care treatment or one the leading drugs under development, in repeated animal in vivo studies. See our Pipeline


  • Re-purposed compounds have a much lower risk of failing in human trials as a result of safety issues.


  • In the planning stages for 4 separate phase II clinical trials.


  • Highly capital efficient business model.


  • Experienced management team & globally recognized medical advisory board.
Share via
Copy link
Powered by Social Snap